Laurus Labs to Acquire 60% Stake in Canadian Biotech Firm Galenvs Sciences for $3.75 Million
The Laurus Labs Galenvs acquisition buys 60% of a Montréal biotech for US$3.75 million. Terms, technology and what is undisclosed.
The Laurus Labs Galenvs acquisition buys 60% of a Montréal biotech for US$3.75 million. Terms, technology and what is undisclosed.